Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of SGLT2-inhibitors on Post Contrast Acute Kidney Injury in Acute Coronary Syndrome Patients Receiving Invasive Strategy

NCT06491953 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT06491953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06491953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of SGLT2-inhibitors on Post Contrast Acute Kidney Injury in Acute Coronary Syndrome Patients Receiving Invasive Strategy
Lead sponsor
Shenyang Northern Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2024
Completion date
May 28, 2026
Enrollment
3,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impact of sglt2-inhibitors on pc-aki in acs patients receiving invasive strategy